Metacognitive skill training for schizophrenic patients

ISRCTN ISRCTN95205723
DOI https://doi.org/10.1186/ISRCTN95205723
Secondary identifying numbers DFG MO 969/6-1 & R03418/1-1
Submission date
22/12/2006
Registration date
26/01/2007
Last edited
07/01/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Steffen Moritz
Scientific

University Medical Center Hamburg-Eppendorf
Martinistrasse 52
Hamburg
20246
Germany

Study information

Study designInterventional randomised controlled observer-blinded parallel-group multicentre study.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleMetacognitive skill training for schizophrenic patients
Study objectives1. Primary objective: assessment of schizophrenic positive symptoms before and after intervention (hypothesis: accelerated symptom decline under experimental intervention)
2. Secondary objective: assessment of metacognitive deficits assumed to underlie delusion formation in schizophrenia before and after intervention (hypothesis: accelerated amelioration of metacognitive deficits under experimental intervention)

Please note that as of 01/11/2012, the target number of participants was updated from 300 to 150, due to an error in the original application
Ethics approval(s)Local ethics committee in Hamburg, 13th November 2006 (ref: 2612).
Health condition(s) or problem(s) studiedSchizophrenia
InterventionExperimental intervention:
MetaCognitive skill Training (MCT) focusing on delusion-relevant metacognitive biases in schizophrenia.

Control intervention:
Cognitive remediation (computer-supported cognitive training program [COGPACK]).

Duration of intervention per patient: four weeks; sessions are scheduled twice weekly.
Intervention typeOther
Primary outcome measureCurrent primary outcome measure as of 01/11/2012:
A delusion score derived from the Positive and Negative Syndrome Scale (PANSS): sum score of items p1 (delusions), p5 (grandiosity) and p6 (suspiciousness)

Previous primary outcome measures until 01/11/2012:
1. Decline on PANSS positive subscale from T1 (baseline) to T2 (four weeks/assessment immediately after the end of intervention)
2. Conventional algorithm (i.e., sum of PANSS positive items one to seven)
Secondary outcome measures1. Improvement of dysfunctional metacognitive biases (i.e., self-serving bias, jumping to conclusions bias, incorrigibility, over-confidence in errors, enhanced need for closure)
2. Subsequent to intervention represents secondary outcome parameter (i.e., difference T1-T2)

Secondary analyses will include follow-up.
Overall study start date01/12/2006
Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants150
Key inclusion criteria1. Patients diagnosed with schizophrenia spectrum disorder
2. Current or prior delusional symptoms
3. Informed consent
4. Clinical stability
Key exclusion criteria1. Age beyond 65
2. Severe brain damage
3. Intelligence Quotient (IQ) less than 70
4. More than or equal to five for ratings on hostility and non-cooperativeness and more than or equal to six on suspiciousness according to Positive And Negative Symptoms Scale (PANSS) interview
5. Incapacity to give informed consent
Date of first enrolment01/12/2006
Date of final enrolment31/12/2009

Locations

Countries of recruitment

  • Germany

Study participating centre

University Medical Center Hamburg-Eppendorf
Hamburg
20246
Germany

Sponsor information

German Research Foundation (DFG)/Federal Ministry of Education and Research (BMBF) (Germany)
Government

Kennedyallee 40
Bonn
53175
Germany

ROR logo "ROR" https://ror.org/018mejw64

Funders

Funder type

Government

Deutsche Forschungsgemeinschaft
Government organisation / National government
Alternative name(s)
German Research Association, German Research Foundation, DFG
Location
Germany
Bundesministerium für Bildung und Forschung
Government organisation / National government
Alternative name(s)
Federal Ministry of Education and Research, BMBF
Location
Germany

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2014 Yes No
Results article results 01/06/2018 Yes No

Editorial Notes

07/01/2019: Publication reference added.